跳至主要内容
临床试验/IRCT20240420061541N1
IRCT20240420061541N1招募中3 期

Investigating and comparison the effect of Pedilact probiotic and Bilinaster in indirect bilirubin level in infants with exaggerated physiological jaundice

Yazd University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 28 days(—)
性别
All

入选标准

  • Term neonate (GA>35w)
  • Birth weight > 2500g
  • Breast milk feeding
  • Indication for phototherapy and hospitalization by Bhutani chart

排除标准

  • Less than 2 days old
  • With a pathological background such as sepsis, favism, congenital anomalies, asphyxia, congenital heart disease and intrauterine growth restriction
  • With a positive Coombs test
  • Undergoing blood transfusion or receiving IVIG
  • Treated with phenobarbital
  • In need of serum therapy
  • Consumption of Formula

研究者

发起方
Yazd University of Medical Sciences

相似试验

Investigating and comparison the effect of Pedilact... | 临床试验